Health officials from China, Korea, India, Taiwan, Malaysia, Bahrain, Turkey, Jordan, United Arab Emirates, Qatar, Morocco, Algeria, Nigeria, Senegal, Cuba, Italy, and 65 scientific studies have shown hydroxychloroquine is effective when used early against COVID19. A thread.

On February 17th, Chinese health officials said that chloroquine was selected out of "tens of thousands of existing drugs after multiple rounds of screening" as the most effective treatment against COVID19.

On February 13th, Korea posted their official treatment guidelines utilizing hydroxychloroquine as a treatment for COVID19.

Health officials from India's ICMR have successfully been using Hydroxychloroquine as treatment and a preventative measure. The tablets are given to police officers, hospital workers, and family members of those who test positive.

The health director of Malaysia credits hydroxychloroquine for their low fatality rates saying, "We use it for patients that have been diagnosed positive, asymptomatic, or mild symptoms... We realize by using hydroxychloroquine, we can delay or even stop the progression."

On March 26th, Taiwain issued interim COVID19 guidelines including the use of hydroxychloroquine with emphasis on early treatment.

Bahrain began using hydroxychloroquine two days after the first case of Covid-19 was discovered there in February. They did this based on "notable success in China and South Korea." Now they have one of the lowest case fatality rates in the world.

In April, Turkey had the biggest coronavirus outbreak in the Middle East. Turkey's Ministry of Health says the realtively low death toll is thanks to a treatment protocol including hydroxychloroquine.

In March, Jordan's FDA authorised physicians to use hydroxychloroquine as a treatment for COVID19 citing international studies.

The Health Minister of the United Arab Emirates credits hydroxychloroquine for reducing the duration of patient's illness and the severity of their symptoms. The nation has been succesfully treating COVID19 patients with HCQ since April.

The Health Minister of Qatar in an interview with Al Jazeera said that Qatar is using hydroxychloroquine with "great success" and has a relatively low case fatality rate compared to other nations.

Despite safety concerns by the World Health Organization, Morocco's health minister says "chloroquine leads to faster recovery" and that they intend to continue usage. Morocco credits hydroxychloroquine for their success in treating COVID19.

Health officials in Algeria have claimed to have "great success" using hydroxychloroquine in combination with antibiotics and have "not noted any adverse reactions" among several thousand patients who have been given the treatment.

Nigeria has found success with using hydroxychloroquine as a prophylaxis for COVID19.

In March, Health Officials from Senegal found "no complications and no deaths in patients treated with hydroxychloroquine". They said they will continue treatment with hydroxychloroquine.

Cuban Medical Authorities have found "early hydroxychloroquine potent against COVID19". Health officials are using low doses of the antimalarial drug to effetively treat patients in the early stages of the disease.

Costa Rica has been using hydroxychloroquine to treat early since a teleconference with health officials from China on March 18th. They now boast one of the lowest fatality rates in the world.

On March 29th, Italy finally began mass treatment with hydroxychloroquine. Italy's death rate peaked a few days later and has continued to drop since then.

On April 2nd, a global survey of 6,000 doctors from 30 countries found hydroxychloroquine as the "most effective therapy" from a list of 15 options.

In July, a professor of epidemiology at Yale wrote a paper claiming that "the data fully supports hydroxychloroquine" and the anti-malarial drug "is the key to defeating COVID19". He argued that "tens of thousands of patients are dying unnecessarily without the drug"

In April, The American Physicians and Surgeons (AAPS) wrote a letter saying that peer reviewed studies since January have provided clear and convincing evidence that HCQ may be beneficial in treating COVID19. In observational studies of 2137 patients, 91.6% improved clinically.

There are now 65 hydroxychloroquine studies that show high effectiveness as an early treatment against COVID19, while late treatment shows mixed results. https://c19study.com/ 

Hydroxychloroquine has been safely prescribed to hundreds of millions since 1955. The CDC website literally says that it can be "safely taken by pregnant women and children". The WHO list it as an essential medicine.

The UVA study was a fraud. HCQ was used after patients were already severe & intubated. The group being treated with HCQ had the highest median age, were the most obese, and had the highest percentage of smokers. This is how the media covered it.

The Lancet Study using the data of "96,032 patients from 671 hospitals in six continents" which led to the World Health Organization suspending clinical trials citing the "danger of hydroxychloroquine" was retracted after it was discovered to be based on fabricated data.

How has Dharavi (setting for "Slumdog Millionaire"), Asia's largest, densest slum had only 71 deaths out of 1,000,000?

The same way India, the second most populated country in the world has, hydroxychloroquine as an early treatment and prophylactic.

How does Africa have a lower death rate than the United States and the rest of the world?

Hydroxychloroquine.

Peer-reviewed, retrospective analysis of 2,541 patients found "Hydroxychloroquine Cut Death Rate Significantly in COVID-19 Patients"

“Our analysis shows that using hydroxychloroquine helped saves lives,” said neurosurgeon Dr. Steven Kalkanis, CEO, Henry Ford Medical Group.